Veterinary Orthopedic Medicine Market Report 2025

This Veterinary Orthopedic Medicine market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The veterinary orthopedic medicine market size has grown strongly in recent years. It will grow from $3.69 billion in 2024 to $4.04 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to emergence of regenerative medicine, telemedicine integration, increasing number of veterinary orthopedic specialists, rise in the adoption of viscosupplementation products, and improving animal health awareness.

The veterinary orthopedic medicine market size is expected to see strong growth in the next few years. It will grow to $5.74 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to rising prevalence of osteoarthritis, increasing adoption of pet insurance, high prevalence of obesity in companion animals, increasing pet ownership, rising pet expenditure. Major trends in the forecast period include hybrid implants, advanced materials, regenerative medicine, 3D imaging, computerized tomography (CT).

The rising incidence of pet orthopedic diseases is expected to drive the growth of the veterinary orthopedic medicine market. Pet orthopedic diseases refer to conditions that affect the musculoskeletal system of companion animals, particularly dogs and cats. The increasing prevalence of these diseases can be attributed to factors such as breed predispositions, higher rates of obesity, and environmental influences like insufficient exercise and poor nutrition. Veterinary orthopedic medicine plays a critical role in diagnosing, treating, and managing these diseases, helping to alleviate pain, restore mobility, and enhance the overall quality of life for pets. For example, in July 2024, a report by the Morris Animal Foundation, a US-based non-profit organization, revealed that over 14 million adult dogs in the United States suffer from osteoarthritis. Furthermore, data shows that around 90% of cats over the age of 12 display radiographic signs of osteoarthritis, emphasizing the high prevalence of this condition in aging pets and highlighting the growing need for awareness and advances in treatment options.

Major companies in veterinary orthopedic medicine are increasingly investing in cutting-edge technologies, such as 3D printing labs for custom implants, regenerative medicine including stem cell and platelet-rich plasma (PRP) therapies, and advanced imaging techniques like MRI and CT scans specifically designed for animal patients. A 3D printing lab for pet orthopedic surgeries is a specialized facility that uses 3D printing technology to create custom implants, prosthetics, and surgical tools tailored for veterinary orthopedic procedures. For example, in October 2024, VCA Animal Hospitals, a U.S.-based provider of high-quality veterinary care for pets, launched a 3D printing lab at its VCA Northwest Veterinary Specialists facility in Clackamas, Oregon. This lab employs advanced 3D printing technology to enhance orthopedic surgeries by creating custom implants and surgical guides designed for each pet's unique anatomy. Osteoarthritis, which affects 20% of dogs older than one year and 80% of those over eight, often requires surgical intervention. By offering a personalized approach, VCA aims to promote faster recovery times and improve surgical outcomes, addressing complex orthopedic conditions more effectively than traditional methods.

In August 2022, Vimian Group AB, a Sweden-based veterinary health company, acquired Veterinary Orthopedic Implants, LLC (VOI) for USD 4.5 million. This acquisition allows Vimian Group AB to expand its presence and capabilities in the veterinary orthopedic sector by integrating VOI's specialized expertise and product portfolio. As a result, Vimian aims to enhance its ability to offer advanced orthopedic solutions and innovative implants to veterinary professionals worldwide, strengthening its position in the global veterinary health market. Veterinary Orthopedic Implants, LLC (VOI), a US-based company, specializes in the development and provision of a wide range of orthopedic implants.

Major companies operating in the veterinary orthopedic medicine market are AmerisourceBergen Corporation, Johnson & Johnson, EVEROST INC, Zoetis Inc., Elanco Animal Health, Integra lifesciences, Ceva Sante Animale, Virbac SA, STERIS Animal Health, Merck Animal Health (Merck & Co. Inc.), Veterinary Orthopedic Implants, American Regent, Bimeda U.S., B. Braun Melsungen AG, Coveto SA, Biogenesis Bago, Vetoquinol S.A., Avante Animal Health, Hyalogic LLC, Hester Biosciences, Petline Sa, Sklar Instruments, GerMedUSA, RWD Life Science, Orthomed (UK) Ltd, BioMedtrix LLC, IMEX Veterinary Inc.

North America was the largest region in the veterinary orthopedic medicine market in 2024. The regions covered in the veterinary orthopedic medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the veterinary orthopedic medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Veterinary orthopedic medicine constitutes a distinct discipline within veterinary practice, concentrating on the identification, management, and prevention of musculoskeletal disorders and injuries in animals. This field encompasses a spectrum of conditions, including fractures, arthritis, congenital abnormalities, and soft tissue injuries, and entails diverse treatment modalities such as surgical procedures, physical therapy, and rehabilitation, all aimed at reinstating mobility and function in animals.

The primary products of veterinary orthopedic medicine include biologics, viscosupplements, and pharmaceuticals. Biologics are derived from living cells or organisms and are utilized to treat diseases or injuries in various animal species such as dogs, cats, horses, cattle, pigs, and others. These products find multiple applications, including the management of osteoarthritis, degenerative joint disease, joint inflammation or pain, and more, and are employed by veterinary hospitals, clinics, and other end-users.

The veterinary orthopedic medicine market research report is one of a series of new reports that provides veterinary orthopedic medicine market statistics, including veterinary orthopedic medicine industry global market size, regional shares, competitors with veterinary orthopedic medicine market share, detailed veterinary orthopedic medicine market segments, market trends, and opportunities, and any further data you may need to thrive in the veterinary orthopedic medicine industry. This veterinary orthopedic medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The veterinary orthopedic medicine market includes revenues earned by entities by providing services such as diagnosing, treating, and preventing musculoskeletal disorders and injuries in animals. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary orthopedic medicine market also includes sales of external fixation devices, intramedullary devices, and joint implants. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.